English | 简体中文 | 繁體中文 | 한국어 | 日本語
Tuesday, 9 July 2024, 23:10 HKT/SGT
Share:
    

Source: AIVF
AIVF Set to Transform the IVF Process With AI Technology in the Australian Market
AIVF, a leading innovator in fertility technology, is thrilled to announce that its cutting-edge AI-driven solutions are now available in the Australian market.

MELBOURNE, July 9, 2024 - (ACN Newswire) - AIVF, a leading innovator in fertility technology, is thrilled to announce that its cutting-edge AI-driven solutions are now available in the Australian market. This milestone brings the promise of enhanced fertility treatments and improved success rates to clinics and patients across Australia.

AIVF's groundbreaking technology is designed to accelerate the time to pregnancy and increase predicted clinical pregnancy success rates, by leveraging advanced artificial intelligence. The inclusion in the Australian market ensures that patients now have access to some of the most sophisticated and well-tested fertility technologies available.

This achievement is the result of five years of intensive research, during which tens of thousands of embryos were analyzed using state-of-the-art AI models and data from five continents. This rigorous process underscores AIVF's commitment to quality and excellence in reproductive health technologies.

"We are excited to bring our innovative solutions to Australia, marking a significant step forward in our mission to support individuals and couples on their journey to parenthood," said Daniella Gilboa, CEO and Co-founder of AIVF. "Our technology is designed to provide a higher standard of care, improving clinical outcomes and optimizing the IVF process."

AIVF's platform enhances the IVF process through predictive analytics and decision support for all Relevant Health Professionals - such as a registered medical practitioner. This technology aims to improve success rates and optimize outcomes for fertility treatment patients, from early-stage embryo evaluation to genetic testing.

Clinics in Australia can now integrate AIVF's solutions into their offerings, providing speedier, more accurate, and seamless IVF treatments. Patients will benefit from less invasive procedures, greater transparency, and higher success rates, ultimately leading to faster times to pregnancy.

This expansion marks a new era in IVF treatment, and AIVF invites clinics and patients across Australia to be part of this groundbreaking transformation.

For more information about AIVF and its innovative fertility solutions, please visit AIVF.co.

About AIVF

AIVF is at the forefront of fertility technology, dedicated to advancing reproductive health through artificial intelligence and data-driven solutions. Their mission is to support fertility clinics and their patients by providing innovative tools that enhance the IVF process and improve clinical outcomes.

Contact Information
Eyal Katz
VP Marketing
eyalk@aivf.co
+972542413730

SOURCE: AIVF



Topic: Press release summary
Source: AIVF

Sectors: Healthcare & Pharm, Artificial Intel [AI]
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
GMG Reaches Market Commercialisation Milestone on Energy Savings Coating THERMAL-XR(R)  
Nov 24, 2024 23:54 HKT/SGT
New Progress in the Merger of Guotai Junan and Haitong Securities  
Nov 24, 2024 18:14 HKT/SGT
CleverTap Recognized as a 'Strong Performer' in the Cross-Channel Marketing Hubs, Q4 2024 Report  
Nov 23, 2024 20:42 HKT/SGT
First Quarterly Profit, High-Quality Platform Growth, NaaS Technology Accelerates Ecosystem Development  
Nov 22, 2024 23:22 HKT/SGT
Tat Hong Equipment Service Co., Ltd. Announces 2024/25 Interim Results  
Nov 22, 2024 19:56 HKT/SGT
Daeshin MC Co., Ltd. Unveils Its Clean Solutions Creating Pleasant Indoor Environments from Industrial Sites to Public Facilities  
Nov 22, 2024 11:00 HKT/SGT
Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against Humacyte, Inc. (HUMA) - Deadline is January 17, 2025  
Friday, November 22, 2024 10:00:00 AM
Jacobson Pharma Announces FY2025 Interim Results  
Nov 22, 2024 10:00 HKT/SGT
NaaS Q3 2024 Recap: Strategic Shifts and Tech Innovations for Growth  
Thursday, November 21, 2024 9:59:00 PM
GMG Unveils SUPER G(R): A Game-Changing Graphene Solution for the Lithium-Ion Battery Industry  
Nov 21, 2024 21:29 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575